In addition, the results from TCGA colorectal dataset indicated that the mRNA expression levels of CXCL17 were significantly higher in rectosigmoid adenocarcinoma (fold change = 2.664, P = 1.25E-5), rectal mucinous adenocarcinoma (fold change = 3.492, P = 1.60E-5), and colon mucinous adenocarcinoma (fold change = 4.178, P = 2.10E-7). This evidence concerns the gene CXCL17 and rectosigmoid adenocarcinoma.